Search for tag: "clinical research"

ACC 2018: What are the takeaways of the ODYSSEY Outcomes Trial?

Dr. Steve Nissen, Chairman of Cardiovascular Medicine, discusses the results the ODYSSEY trail looking at the PCSK9 inhibitor alirocumab in patients who had a prior acute coronary syndrome and were…

From  ConsultQD Live Admin 0 likes 15 plays

Bioabsorbable Stents – Where are we now?

Dr. Stephen Ellis summarizes the discussions surrounding bioabsorbable scaffolding or stents: why they were hypothesized, the results of the trials; and where we are now.

From  Lori Kohut 0 likes 60 plays

ESC 2017: Highlights of late breaking trials

Dr. Steve Nissen discusses the results of three important late breaking trials looking at the impact of three drugs on cardiovascular endpoints: the CANTOS trial (Canakinumab); the REVEAL study…

From  ConsultQD Live Admin 0 likes 23 plays

Fractional Flow Reserve (FFR) vs. Instantaneous Wave-Free Radio (iFR) in the Cath Lab

Dr. Stephen Ellis discusses the results of recent trials at ACC related to Instantaneous Wave-Free Ration (iFR) and how the results impact practice in the cath lab.

From  ConsultQD Live Admin 0 likes 136 plays

Bioresorbable Stents: Making sense of recent trial data

Dr. Stephen Ellis discusses the results of recent bioresorbable stent trials including the ABSORB III trial and what the results mean for clinical practice.

From  ConsultQD Live Admin 0 likes 56 plays